BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 16757497)

  • 1. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K; Novak J; Yanagihara T; Tomana M; Moldoveanu Z; Kulhavy R; Julian BA; Konecny K; Mestecky J
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.
    Schena FP; Pastore A; Ludovico N; Sinico RA; Benuzzi S; Montinaro V
    Clin Exp Immunol; 1989 Jul; 77(1):15-20. PubMed ID: 2788538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
    Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D; Paradisi L; Baiocchi C; Medana C; Lo Duca G; Sena LM; Roccatello D
    J Nephrol; 2007; 20(6):689-95. PubMed ID: 18046671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. The role of asialoglycoprotein receptors.
    Roccatello D; Picciotto G; Torchio M; Ropolo R; Ferro M; Franceschini R; Quattrocchio G; Cacace G; Coppo R; Sena LM
    Lab Invest; 1993 Dec; 69(6):714-23. PubMed ID: 8264233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.
    Coppo R; Amore A; Chiesa M; Lombardo F; Cirina P; Andrulli S; Passerini P; Conti G; Peruzzi L; Giraudi R; Messina M; Segoloni G; Ponticelli C
    Clin Transplant; 2007; 21(6):728-37. PubMed ID: 17988266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of serum von Willebrand factor and anti-endothelial cell antibodies in patients with immunoglobulin A nephropathy are associated with intrarenal arterial lesions.
    Zhang JJ; Jiang L; Liu G; Wang SX; Zou WZ; Zhang H; Zhao MH
    Nephrology (Carlton); 2008 Dec; 13(8):712-20. PubMed ID: 18771467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies.
    van den Wall Bake AW; Beyer WE; Evers-Schouten JH; Hermans J; Daha MR; Masurel N; van Es LA
    J Clin Invest; 1989 Oct; 84(4):1070-5. PubMed ID: 2794045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H; Yamamoto K; Iwayama S; Iwase H; Takasaki A; Takahashi K; Fujita Y; Sugiyama S; Hiki Y
    J Nephrol; 2010; 23(1):70-6. PubMed ID: 20091489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of IgG subclass antibody response to tetanus toxoid associated with high serum IgA levels in IgA nephropathy.
    Layward L; Allen AC; Harper SJ; Hattersley JM; Feehally J
    Clin Nephrol; 1993 Sep; 40(3):131-6. PubMed ID: 8403566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on anti-IgA antibody in patients with IgA nephropathy.
    Seino S
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):361-9. PubMed ID: 1635281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy.
    de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C
    Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA; Wittke S; Novak J; Good DM; Coon JJ; Kellmann M; Zürbig P; Schiffer E; Haubitz M; Moldoveanu Z; Calcatera SM; Wyatt RJ; Sýkora J; Sládková E; Hes O; Mischak H; McGuire BM
    Electrophoresis; 2007 Dec; 28(23):4469-83. PubMed ID: 18004714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study.
    Coppo R; Amore A; Gianoglio B; Porcellini MG; Peruzzi L; Gusmano R; Giani M; Sereni F; Gianviti A; Rizzoni G
    Clin Nephrol; 1995 Jan; 43(1):1-13. PubMed ID: 7697930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different appearance and pathogenic roles of serum IgA against autologous IgG Fc and Fab in patients with IgA nephropathy.
    Yashiro M; Muso E; Yoshida H; Shimada T; Matsushima M; Sawanishi K; Sugiyama T; Kawai C
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):497-506. PubMed ID: 1895549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
    Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
    Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
    Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mannose-binding protein gene polymorphism influences the patterns of glomerular immune deposition in IgA nephropathy].
    Gong R; Liu Z; Chen Z; Liu D; Li L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):83-7. PubMed ID: 11295122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.